CPIX(Cumberland Pharmaceuticals Inc.) · 财务报表

CPIX(Cumberland Pharmaceuticals Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$35.99M$42.01M$39.55M$37.87M$44.52M
毛利润$27.17M$32.89M$33.49M$31.28M$37.85M
营业利润−$7.68M−$5.70M−$9.55M−$6.43M−$2.79M
净利润−$3.51M−$5.57M−$6.28M−$6.48M−$2.84M
经营现金流$6.34M$8.45M$6.09M−$612.19K$4.93M
自由现金流$6.24M$8.35M$5.81M−$678.65K$4.83M
摊薄每股收益$-0.24$-0.38$-0.44$-0.46$-0.19

Cumberland Pharmaceuticals Inc. CPIX